Abstract
Health misinformation can complicate clinical conversations, influence expectations, and place additional pressure on trust between patients and healthcare professionals. Medical Science Liaisons (MSLs), as field-based Medical Affairs professionals, may help healthcare professionals navigate this environment through accurate, balanced, and non-promotional scientific exchange. Their contribution is mainly indirect: MSLs support healthcare professionals, identify recurring information gaps, collaborate with Medical Information and other Medical Affairs colleagues, and help shape evidence-based educational responses within applicable legal, regulatory, and company frameworks. This article examines the relationship between digital misinformation and the doctor-patient relationship, clarifies where MSLs can add value, and identifies the competencies needed for responsible practice. It also argues that structured training and continued professional development can strengthen scientific appraisal, communication, ethical judgment, and insight generation, although training alone does not guarantee career progression or impact. A practice-based composite example illustrates how an MSL team might respond when clinicians report a recurring misinformation theme. The central conclusion is that MSLs can form part of a coordinated response to misinformation when their work remains scientifically rigorous, appropriately governed, and connected to the information needs of healthcare professionals and patients.
Keywords: health misinformation, Medical Science Liaison, Medical Affairs, doctor-patient relationship, scientific exchange, health literacy, professional development, training
1 Introduction
Patients have always sought health information beyond the consulting room. Digital platforms have changed the scale, speed, and visibility of that behaviour. Search engines, social networks, patient communities, video platforms, and generative artificial intelligence can improve access to useful information, yet they also expose patients to content that is inaccurate, incomplete, outdated, or presented without the context needed for clinical decisions. Reviews of health misinformation show that the problem spans several therapeutic areas and is shaped by both platform dynamics and human factors such as prior beliefs, emotion, and trust [1-3].
The consequences for clinical practice are not uniform. Online information can help patients prepare questions and participate more actively in decisions. It can also create confusion, reinforce unrealistic expectations, or make a patient less willing to accept a recommended intervention. A systematic review of patients’ use of social media found both beneficial and adverse effects on the relationship with healthcare professionals [4]. The relevant question is therefore not whether patients should search for information, but how healthcare systems can help them interpret evidence and discuss uncertainty constructively.
This article considers one part of that response: the potential contribution of Medical Science Liaisons. It does not position MSLs as fact-checkers for the public or as substitutes for clinicians. Instead, it examines how their established responsibilities in scientific exchange, evidence interpretation, insight generation, and medical education may help healthcare professionals respond to recurring misinformation themes within an appropriate governance framework.
2 Misinformation and the doctor-patient relationship
Health misinformation is often defined as health-related information that is false or misleading according to the best available evidence at a particular time. That definition requires care because medical evidence changes. An early finding may later be revised, and legitimate scientific uncertainty should not be treated as deliberate deception. Effective responses must therefore distinguish demonstrably false claims from evolving evidence, reasonable disagreement, and differences in clinical judgment [2,3].
Misinformation can enter the consultation in several forms. A patient may arrive with a viral claim about treatment safety, a testimonial promoting an unproven alternative, or an oversimplified interpretation of a scientific study. The physician must then address the health issue and the information issue at the same time. Dismissing the patient’s concern may damage trust, whereas accepting the claim without scrutiny may expose the patient to harm. Arora and colleagues recommend that clinicians first understand the concern, identify the source, respond with credible evidence, and preserve the relationship rather than turning the encounter into a confrontation [5].
Communication quality matters. In a cross-sectional analysis of nationally representative US data, participants who reported better patient-provider communication had lower odds of watching health-related videos on YouTube, although the design does not establish causality [6]. This finding supports a cautious but practical interpretation: when patients have time to ask questions and receive explanations they understand, they may have less need to fill information gaps elsewhere. It does not imply that online searching is inherently harmful or that communication alone can eliminate misinformation.
3 Where MSLs fit within Medical Affairs
MSLs are field-based Medical Affairs professionals who conduct scientific exchange with healthcare professionals and other permitted stakeholders. Position statements describe the role as non-promotional and grounded in accurate, balanced, and clinically relevant communication [7,8]. The exact scope varies by country, company, therapeutic area, product lifecycle, and organizational model. In some settings, MSLs also contribute to evidence generation, medical education, research collaboration, and the structured collection of medical insights.
This variation is important. Broad claims that MSLs directly educate patients, correct public discourse, or lead public-health campaigns may not reflect local rules or company policy. Direct engagement with patients or the public may sit with Medical Information, patient engagement, corporate affairs, public health bodies, or external clinical organizations. An MSL may contribute scientific expertise to these activities, but only through approved processes and with clear separation from promotional objectives.
Within those boundaries, MSLs can add value in four related ways:
- Scientific exchange. MSLs can help healthcare professionals interpret new evidence, understand study limitations, and place a contested claim within the broader evidence base.
- Insight generation. Recurring questions from healthcare professionals can signal an unmet information need. When documented and analysed appropriately, these insights can inform medical strategy, educational priorities, evidence-generation plans, or Medical Information responses.
- Cross-functional scientific coordination. MSLs can connect field observations with Medical Information, safety, evidence generation, patient engagement, and communications teams, while respecting each function’s responsibilities.
- Education for healthcare professionals. Where permitted, MSLs may support non-promotional education on disease science, evidence appraisal, benefit-risk communication, and areas of uncertainty.
Survey research in Spain suggests that healthcare professionals value MSL involvement in research projects and training activities, while also confirming that expectations differ across stakeholders [9]. Such findings support the relevance of the role, but they should not be interpreted as proof that every MSL activity improves patient outcomes. Direct evidence linking specific MSL interventions to clinical outcomes remains limited, and impact assessment should therefore use realistic measures such as relevance, timeliness, scientific quality, changes in understanding, and identified evidence gaps.
4 Competencies, career development, and the value of training
Scientific knowledge is necessary for MSL practice, but it is rarely sufficient on its own. Published standards and competency frameworks also emphasise communication, evidence appraisal, compliance, stakeholder engagement, insight generation, and professional judgment [7,8,11]. In a survey used to inform an advanced MSL curriculum, healthcare professionals highlighted product knowledge, scientific credibility, therapeutic-area expertise, timely responses, and communication skills [10]. These expectations are related, but they develop at different rates and require different forms of learning.
Career progression in Medical Affairs does not follow a single formula. Advanced degrees, therapeutic expertise, field experience, business understanding, leadership capability, and cross-functional exposure may all contribute, depending on the role and organization. A professional who wants to remain a high-level scientific specialist may need a different development plan from someone preparing to lead a field medical team or move into medical strategy. It is therefore more accurate to describe development as context-dependent than to suggest that one qualification, behaviour, or training programme determines success.
Structured training can nevertheless reduce avoidable variability and give professionals a common standard for practice. Initial training should normally cover disease and product science, study design, critical appraisal, medical governance, pharmacovigilance responsibilities, scientific exchange, insight documentation, and the distinction between medical and promotional communication. Continued development may then focus on advanced communication, digital and data literacy, facilitation, leadership, mentoring, and the evaluation of emerging evidence. The Medical Affairs Professional Society similarly presents capability needs as a broad portfolio that varies by role and level of responsibility [11].
The value of training should be assessed carefully. Completion rates and certificates show participation, not competence. More meaningful evaluation may include observed scientific discussions, case-based assessments, quality of written insights, response accuracy, compliance with escalation processes, and feedback from healthcare professionals and managers. Training works best when it is reinforced through coaching, field observation, peer review, and opportunities to apply the learning. Even then, improved performance depends on organizational support, workload, data access, leadership, and the quality of the medical strategy.
Misinformation adds several development needs. MSLs require the ability to distinguish false claims from scientific uncertainty, explain risk without overstating certainty, recognise emotionally charged conversations, and identify when a question should be escalated to Medical Information, safety, legal, or compliance colleagues. The World Health Organization’s infodemic-management framework highlights listening, audience understanding, intervention design, evaluation, and workforce development as relevant competencies for health institutions [12]. MSL teams can adapt selected elements of this framework to their remit, provided that the activity remains within local governance requirements.
5 Practice-based composite example
The following composite scenario reflects common field medical and Medical Information workflows rather than a single company case. Several physicians tell an MSL that patients are refusing an indicated therapy after viewing short videos claiming that the treatment causes a serious adverse event in most users. The MSL does not argue with patients online or provide individual medical advice. Instead, the MSL records the recurring question as a medical insight, checks whether the claim involves a reportable safety event, and asks Medical Information to review the available evidence and existing response documents.
The review finds that the videos misrepresent a small observational study and omit the larger evidence base. Medical Information prepares an approved, balanced summary that explains the study design, absolute risk, known uncertainty, and relevant safety monitoring. The field medical team receives a short case-based session on how to discuss the evidence with healthcare professionals without dismissing patient concerns. During subsequent scientific exchanges, the MSL asks physicians which parts of the explanation are most useful and whether new questions are emerging.
In this scenario, training makes a practical difference by helping the MSL recognise the misinformation pattern, document it consistently, communicate risk accurately, and use the correct escalation route. The example does not assume that the intervention changes prescribing or patient outcomes. A proportionate evaluation would first examine response quality, consistency, timeliness, and whether healthcare professionals report greater confidence in addressing the claim. Any assessment of clinical impact would require a more rigorous design.
6 Practical principles for Medical Affairs teams
Organizations considering a more systematic response to misinformation can begin with a small number of operational principles:
- Define the remit. Clarify which misinformation-related activities belong to MSLs, Medical Information, safety, compliance, patient engagement, communications, and external partners.
- Create a field-to-function insight pathway. Use a consistent method to document recurring claims, their sources, the affected stakeholders, and the clinical questions they generate.
- Prioritise by potential harm and frequency. Not every inaccurate statement requires a formal response. Focus on claims that may affect safety, treatment decisions, adherence, or trust.
- Use approved, balanced responses. Address absolute risk, evidence quality, uncertainty, and the limits of current knowledge. Avoid replacing one oversimplification with another.
- Evaluate understanding before claiming impact. Measure whether stakeholders received a timely and useful scientific response. Treat downstream behavioural or clinical outcomes as separate research questions.
7 Discussion and conclusion
Health misinformation places additional pressure on consultations because clinicians must respond to both a medical problem and a contested information environment. The available literature supports careful communication, credible evidence, and respect for the patient’s concerns. It does not support a single universal intervention, and the effectiveness of different approaches will vary by topic, audience, and context [2,5,14].
MSLs can contribute to this work because their role already involves scientific exchange, evidence interpretation, and the identification of unmet information needs. Their contribution is most credible when it remains non-promotional, transparent about uncertainty, connected to Medical Information and governance processes, and focused on the needs of healthcare professionals. Claims that MSLs can independently correct misinformation at population level would overstate both their mandate and the available evidence.
Training and continued development can strengthen the competencies required for this contribution, especially critical appraisal, communication, ethical judgment, and insight generation. However, training is one part of a wider system. Professional growth and field impact also depend on role clarity, coaching, access to evidence, organizational culture, and opportunities to apply learning. A balanced view therefore recognises the value of MSLs without treating the role as a complete solution to misinformation. Their greatest contribution may lie in helping healthcare professionals receive timely, contextualised, and scientifically responsible information when difficult questions reach clinical practice.
AI use disclosure
Generative artificial intelligence tools were used to support language editing, restructuring, and the identification of candidate references. The author reviewed and revised the manuscript, verified the cited sources, and accepts responsibility for the final content. No research data were generated or analysed using artificial intelligence for this article.
References
- Wang Y, McKee M, Torbica A, Stuckler D. Systematic literature review on the spread of health-related misinformation on social media. Social Science & Medicine. 2019;240:112552. https://doi.org/10.1016/j.socscimed.2019.112552
- Swire-Thompson B, Lazer D. Public health and online misinformation: challenges and recommendations. Annual Review of Public Health. 2020;41:433-451. https://doi.org/10.1146/annurev-publhealth-040119-094127
- Southwell BG, Niederdeppe J, Cappella JN, et al. Misinformation as a misunderstood challenge to public health. American Journal of Preventive Medicine. 2019;57(2):282-285. https://doi.org/10.1016/j.amepre.2019.03.009
- Smailhodzic E, Hooijsma W, Boonstra A, Langley DJ. Social media use in healthcare: a systematic review of effects on patients and on their relationship with healthcare professionals. BMC Health Services Research. 2016;16:442. https://doi.org/10.1186/s12913-016-1691-0
- Arora VM, Madison S, Simpson L. Addressing medical misinformation in the patient-clinician relationship. JAMA. 2020;324(23):2367-2368. https://doi.org/10.1001/jama.2020.4263
- Langford A, Loeb S. Perceived patient-provider communication quality and sociodemographic factors associated with watching health-related videos on YouTube: a cross-sectional analysis. Journal of Medical Internet Research. 2019;21(5):e13512. https://doi.org/10.2196/13512
- Theron P, Britland M, Holder D, et al. Promoting best practices for Medical Science Liaisons: position statement from the APPA, IFAPP, MAPS and MSLS. Therapeutic Innovation & Regulatory Science. 2021;55:1139-1144. https://doi.org/10.1007/s43441-021-00310-y
- Tomiyasu M, Hayashi K, Moritsugu Y, et al. Proposal of standard for Medical Science Liaison profession in Japan: a viewpoint from the Japanese Association of Pharmaceutical Medicine. Pharmaceutical Medicine. 2020;34(5):315-326. https://doi.org/10.1007/s40290-020-00355-8
- González Del Castillo A, García C, Matesanz-Marín A, Gómez-Sánchez MJ, Sastre V. The Medical Science Liaison role in Spain: a survey about the opinion of healthcare professionals. Therapeutic Innovation & Regulatory Science. 2022;56(1):96-103. https://doi.org/10.1007/s43441-021-00333-5
- Moss RJ, Smith EB, Anderson G, et al. A survey of key opinion leaders to support curriculum development in advanced Medical Science Liaison training. Therapeutic Innovation & Regulatory Science. 2015;49(1). https://doi.org/10.1177/2168479014549859
- Medical Affairs Professional Society. What is Medical Affairs? Medical Affairs Professional Society; 2022. https://medicalaffairs.org/wp-content/uploads/2022/05/What-Is-Medical-Affairs-FINAL.pdf
- World Health Organization. Building a response workforce to manage infodemics. World Health Organization; 2021. https://www.who.int/publications/i/item/9789240035287
- Chou WYS, Gaysynsky A, Cappella JN. Where we go from here: health misinformation on social media. American Journal of Public Health. 2020;110(S3):S273-S275. https://doi.org/10.2105/AJPH.2020.305905
- Tan SSL, Goonawardene N. Internet health information seeking and the patient-physician relationship: a systematic review. Journal of Medical Internet Research. 2017;19(1):e9. https://doi.org/10.2196/jmir.5729
About the author:

Amilcar Barreto, MSc
Amilcar is a visiting lecturer in Marketing Communication and strategy at the Universidade Católica Portuguesa (Instituto de Ciências da Saúde). Mr. Barreto’s main research interests are digital communication, namely the pharmaceutical digital communication, consumer digital communication, and omnichannel.
Amilcar shares his time working in global positions in a big Pharma company where he is responsible for multichannel & digital communication in neuroscience and rare disease, and researcher in Universidade Católica Portuguesa, where he is finishing his PhD in Communication Sciences.
Mr. Barreto is a team leader and an active player in different teams, creating integrated strategies. He has been working for almost two decades in different positions in marketing communications in the pharmaceutical industry and fast-moving consumer goods, in companies such as J&J, Roche, and Novartis
Have an opinion on this article? Send a message to the editor.